KBC GROUP NV – Regeneron Pharmaceuticals, Inc. Transaction History
KBC GROUP NV portfolio value:
$42.65M
portfolio value
KBC GROUP NV quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -25.26% | -20.92K shares | -6.31M | $688.87 | 61.92K |
Q2 2022 | share | Decrease | -4.50% | -3.9K shares | -11.61M | $591.13 | 82.85K |
Q1 2022 | share | Decrease | -62.65% | -145.49K shares | -86.07M | $698.42 | 86.75K |
Q4 2021 | share | Increase | +60.91% | 87.90K shares | 59.31M | $642.51 | 232.24K |
Q3 2021 | share | Increase | +9.48% | 12.49K shares | 13.71M | $605.18 | 144.33K |
Q2 2021 | share | Decrease | -10.75% | -15.87K shares | 3.74M | $558.54 | 131.84K |
Q1 2021 | share | Increase | +2.39% | 3.44K shares | 190K | $473.14 | 147.71K |
Q4 2020 | share | Increase | +12.00% | 15.46K shares | -2.40M | $483.11 | 144.27K |
Q3 2020 | share | Increase | +88.86% | 60.60K shares | 29.56M | $559.78 | 128.81K |
Q2 2020 | share | Increase | +110.75% | 35.84K shares | 26.73M | $623.65 | 68.20K |
Q1 2020 | share | Decrease | -26.22% | -11.50K shares | -667K | $488.29 | 32.36K |
Q4 2019 | share | Decrease | -2.85% | -1.28K shares | 3.94M | $375.48 | 43.86K |
Q3 2019 | share | Decrease | -7.15% | -3.47K shares | -2.69M | $277.4 | 45.15K |
Q2 2019 | share | Increase | +25.60% | 9.91K shares | -677K | $313 | 48.62K |
Q1 2019 | share | Increase | +172.44% | 24.50K shares | 10.59M | $410.62 | 38.71K |
Q4 2018 | share | Increase | +16.60% | 2.02K shares | 383K | $373.5 | 14.21K |
Q3 2018 | share | Increase | +85.57% | 5.62K shares | 2.65M | $404.04 | 12.18K |
Q2 2018 | share | Increase | +5.04% | 315 shares | 113K | $344.99 | 6.56K |
Q1 2018 | share | Decrease | -11.74% | -832 shares | -511K | $344.36 | 6.25K |
Q4 2017 | share | Decrease | -19.63% | -1.73K shares | -1.27M | $375.96 | 7.08K |
Q3 2017 | share | Increase | +12.52% | 981 shares | 94K | $447.12 | 8.81K |
Q2 2017 | share | Decrease | -5.82% | -484 shares | 624K | $491.14 | 7.83K |
Q1 2017 | share | Increase | +13.08% | 962 shares | 523K | $387.51 | 8.31K |
Q4 2016 | share | Decrease | -36.48% | -4.22K shares | -1.95M | $367.09 | 7.35K |
Q3 2016 | share | Decrease | -22.70% | -3.40K shares | -577K | $402.02 | 11.58K |
Q2 2016 | share | Increase | +4.53% | 649 shares | 66K | $349.23 | 14.98K |
Q1 2016 | share | Decrease | -1.85% | -270 shares | -2.76M | $360.44 | 14.33K |